Сингапур -
Енглески -
HSA (Health Sciences Authority)
leuprorelin sandoz implant in syringe 5 mg
sandoz singapore pte. ltd. - leuprorelin acetate eqv. leuprorelin - implant - leuprorelin acetate eqv. leuprorelin 5.0 mg
Израел -
Енглески -
Ministry of Health
eligard 22.5 mg
kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 22.5 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
Израел -
Енглески -
Ministry of Health
eligard 45 mg
kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 45 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
Израел -
Енглески -
Ministry of Health
eligard 7.5 mg
kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 7.5 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
Нови Зеланд -
Енглески -
Medsafe (Medicines Safety Authority)
lucrin
abbvie limited - leuprorelin acetate 5 mg/ml - solution for injection - 5 mg/ml - active: leuprorelin acetate 5 mg/ml excipient: benzyl alcohol glacial acetic acid sodium chloride sodium hydroxide water for injection - lucrin (leuprorelin acetate) is indicated · in metastatic prostate cancer · in locally advanced prostate cancer, as an alternative to surgical castration · as an adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer · as an adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression
Ирска -
Енглески -
HPRA (Health Products Regulatory Authority)
leuprex 3, 5mg implant
rowex ltd - leuprorelin acetate - implant - 3 mg, 5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
Аустралија -
Енглески -
Department of Health (Therapeutic Goods Administration)
lucrin depot 3
abbvie pty ltd - leuprorelin acetate, quantity: 22.5 mg - injection, modified release - excipient ingredients: mannitol; polylactic acid - in the palliative treatment of metastatic or locally extensive prostatic cancer. (stage c and d).
Аустралија -
Енглески -
Department of Health (Therapeutic Goods Administration)
lucrin depot 7.5mg powder for injection prefilled dual-chamber syringe with 23 g needle
abbvie pty ltd - leuprorelin acetate, quantity: 7.5 mg - injection, modified release - excipient ingredients: gelatin; mannitol; polyglactin - lucrin depot 7.5 mg injection and lucrin depot 3 month 22.5mg injection and lucrin depot 4 month 30mg injection are indicated in the palliative treatment of metastatic or locally extensive prostatic cancer (stage c and d).
Белгија -
Енглески -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
depo-eligard 45 mg inj. sol. (pwdr. + solv.) s.c. pre-filled syr.
recordati industria chimica e farmaceutica s.p.a. - leuprorelin acetate 45 mg - eq. leuprorelin 41,7 mg - powder and solvent for solution for injection - 45 mg - leuprorelin acetate 45 mg - leuprorelin
Ирска -
Енглески -
HPRA (Health Products Regulatory Authority)
prostap 3 dcs 11.25 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe
pco manufacturing ltd. - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection in pre-filled syringe - 11.25 milligram(s) - leuprorelin